<DOC>
	<DOCNO>NCT00267020</DOCNO>
	<brief_summary>The purpose research study determine effect toxicity gemcitabine alone gemcitabine plus enzastaurin patient pancreatic cancer .</brief_summary>
	<brief_title>Phase 2 Study Gemcitabine Gemcitabine + Enzastaurin Patients With Advanced Metastatic Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Diagnosis adenocarcinoma pancreas . Pretreatment tumor specimen must available . No prior chemotherapy immunotherapy , biological therapy , hormonal therapy pancreatic cancer , include 5FU radiation therapy . Prior radiation allow . Ability stop type antiseizure medicine within 14 day enrollment . Endocrine pancreatic tumor ampullary cancer . Central Nervous System metastases . Inability swallow tablet . 10 % great weight loss 6 week study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>